Relmada Therapeutics stock price
NASDAQ:RLMD · Nasdaq · Healthcare · sector #16Relmada Therapeutics's chart data is dated 2026-10-21. Recorded technical signals: MACD bullish cross. The display ticker is RLMD.
Relmada Therapeutics last closed at $3.21 (-4.46%) on 2026-10-21. Signals today: MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -6.1×. Its overall grade ranks 225 of 726 stocks in Healthcare.
About this company
Relmada Therapeutics last closed at $3.21 (-4.46%) on 2026-10-21. Signals today: MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B+ · 225/726
Valuation grade A
Related stocks
- Sage TherapeuticsCompetitor
- Axsome TherapeuticsCompetitor
- Johnson & JohnsonCompetitor
ETFs holding this stock
AdvisorShares Psychedelics ETF
Details →About Relmada Therapeutics
- What technical signals does Relmada Therapeutics (RLMD) have?
- Relmada Therapeutics current technical signals: MACD bullish cross.
- Is Relmada Therapeutics a cup-and-handle pattern?
- No. Relmada Therapeutics has no valid Cup signal right now.
- What published figures are available for Relmada Therapeutics?
- Market cap: $235.4M. Trailing 12 months PER: -6.1×. Latest quarter PBR: 1.83×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Relmada Therapeutics, or open the plan table on the main site.
Ask Q about Relmada Therapeutics.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.